These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6365780)
1. Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide. Nelson RD; Herron MJ; McCormack RT; Gehrz RC Infect Immun; 1984 Mar; 43(3):1041-6. PubMed ID: 6365780 [TBL] [Abstract][Full Text] [Related]
2. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. Podzorski RP; Gray GR; Nelson RD J Immunol; 1990 Jan; 144(2):707-16. PubMed ID: 2153174 [TBL] [Abstract][Full Text] [Related]
3. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Wright CD; Bowie JU; Gray GR; Nelson RD Infect Immun; 1983 Oct; 42(1):76-80. PubMed ID: 6311754 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites. Podzorski RP; Herron MJ; Fast DJ; Nelson RD Arch Surg; 1989 Nov; 124(11):1290-4. PubMed ID: 2684094 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. Lipsky PE J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652 [TBL] [Abstract][Full Text] [Related]
6. Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme. Wright CD; Herron MJ; Gray GR; Holmes B; Nelson RD Infect Immun; 1981 May; 32(2):731-8. PubMed ID: 6265362 [TBL] [Abstract][Full Text] [Related]
9. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Mpofu CM; Campbell BJ; Subramanian S; Marshall-Clarke S; Hart CA; Cross A; Roberts CL; McGoldrick A; Edwards SW; Rhodes JM Gastroenterology; 2007 Nov; 133(5):1487-98. PubMed ID: 17919633 [TBL] [Abstract][Full Text] [Related]
10. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Nelson RD; Shibata N; Podzorski RP; Herron MJ Clin Microbiol Rev; 1991 Jan; 4(1):1-19. PubMed ID: 2004345 [TBL] [Abstract][Full Text] [Related]
11. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Tada H; Nemoto E; Shimauchi H; Watanabe T; Mikami T; Matsumoto T; Ohno N; Tamura H; Shibata K; Akashi S; Miyake K; Sugawara S; Takada H Microbiol Immunol; 2002; 46(7):503-12. PubMed ID: 12222939 [TBL] [Abstract][Full Text] [Related]
12. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Fischer A; Pichat L; Audinot M; Griscelli C Clin Exp Immunol; 1982 Mar; 47(3):653-60. PubMed ID: 6211308 [TBL] [Abstract][Full Text] [Related]
13. Influence of yeast mannan on release of myeloperoxidase by human neutrophils: determination of structural features of mannan required for formation of myeloperoxidase-mannan-neutrophil complexes. Wright CD; Bowie JU; Nelson RD Infect Immun; 1984 Feb; 43(2):467-71. PubMed ID: 6319284 [TBL] [Abstract][Full Text] [Related]
14. Mitogenic effect of the mannans from Saccharomyces cerevisiae on mouse spleen lymphocytes. Mikami T; Nagase T; Matsumoto T; Suzuki M; Suzuki S; Kumano N Microbiol Immunol; 1982; 26(10):913-22. PubMed ID: 6761557 [TBL] [Abstract][Full Text] [Related]
15. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. Durandy A; Fischer A; Le Deist F; Drouhet E; Griscelli C J Clin Immunol; 1987 Sep; 7(5):400-9. PubMed ID: 2958495 [TBL] [Abstract][Full Text] [Related]
16. The effects of soluble Saccharomyces cerevisiae mannan on the phagocytosis of Candida albicans by mouse peritoneal macrophages in vitro. Kolotila MP; Rogers AL; Beneke ES; Smith CW J Med Vet Mycol; 1987 Apr; 25(2):85-96. PubMed ID: 3298606 [TBL] [Abstract][Full Text] [Related]
17. Nitrocellulose-RAST analysis of allergenic cross-reactivity of Candida albicans and Saccharomyces cerevisiae mannans. Nermes M; Savolainen J; Kortekangas-Savolainen O Int Arch Allergy Immunol; 1995 Feb; 106(2):118-23. PubMed ID: 7819739 [TBL] [Abstract][Full Text] [Related]
18. Candida albicans mannan- and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients. Savolainen J; Kosonen J; Lintu P; Viander M; Pène J; Kalimo K; Terho EO; Bousquet J Clin Exp Allergy; 1999 Jun; 29(6):824-31. PubMed ID: 10336600 [TBL] [Abstract][Full Text] [Related]
19. [Adherence of Candida albicans is inhibited by yeast mannan]. Iwamoto L; Watanabe T; Ogasawara A; Mikami T; Matsumoto T Yakugaku Zasshi; 2006 Mar; 126(3):167-72. PubMed ID: 16508240 [TBL] [Abstract][Full Text] [Related]
20. Polysaccharide mannan components of Candida albicans and Saccharomyces cerevisiae cell wall produce fever by intracerebroventricular injection in rats. Doğan MD; Ataoğlu H; Ataoğlu O; Akarsu ES Brain Res Bull; 1999 Mar; 48(5):509-12. PubMed ID: 10372511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]